Elevance Health

Forecast & Rating22 analysts currently cover Elevance Health, with about 68.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $482.38, about 14.8% upside from the current price of $420.07. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 29.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Elevance Health closely still see room for the stock to rise. Data as of Oct 30, 2026; for reference only and not investment advice.